查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553517

臨床風險分組解決方案市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2024-2030 年

Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Population Health Management, Chronic Disease Management), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床風險分組解決方案市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球臨床風險分組解決方案市場規模預計將達到16.7億美元，2024年至2030年複合年成長率為13.13%。

該市場包括各種旨在有效評估和管理醫療保健環境中患者風險的工具和技術。

資料分析和技術的進步對於推動市場向前發展至關重要。將人工智慧 (AI) 和機器學習 (ML) 納入臨床風險分組解決方案將顯著提高預測結果的能力，使醫療保健提供者能夠做出更明智的決策。

隨著醫療保健提供者努力在控制成本的同時改善患者的治療結果，對全面的人口健康管理解決方案的需求不斷成長。這些解決方案使醫療保健組織能夠有效分析患者資料、識別高風險患者並實施預防策略。

臨床風險分組解決方案市場報告亮點

  • 以產品來看，軟體佔最大市場佔有率，2023年將達77.46%。隨著電子健康記錄（EHR）和先進分析工具的使用越來越多，對根據臨床風險準確分類患者、支援個人化治療計劃和改善患者治療結果的軟體解決方案的需求不斷增加。
  • 從應用來看，人口健康管理佔最大市場佔有率，2023年將達33.20%。該部分整合了來自不同來源的患者資料，包括電子健康記錄、申請資料和健康的社會決定因素，並經過客製化以查明高風險個體並改善整體健康結果，從而製定適當的干涉措施。
  • 從最終用途來看，醫院和診所佔據市場主導地位，2023 年收益佔有率最高，達 48.30%。這些機構採用臨床風險分組解決方案，根據健康狀況、治療要求和潛在風險對患者進行分類，從而實現個人化護理計劃，從而改善患者管理並降低成本。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章：臨床風險分組解決方案市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 臨床風險分組解決方案市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章臨床風險分組解決方案市場：按產品估計和趨勢分析

  • 全球臨床風險分組解決方案市場：按產品分類的儀表板
  • 全球臨床風險分組解決方案市場：按產品分類的變異分析
  • 按產品分類的收益
  • 軟體
  • 服務

第5章臨床風險分組解決方案市場：按應用進行估計和趨勢分析

  • 全球臨床風險分組解決方案市場：按應用分類的儀表板
  • 全球臨床風險分組解決方案市場：按應用進行變異分析
  • 全球臨床風險分組解決方案市場：按應用分類的收益
  • 人口健康管理
    • 2018-2030年市場估計與預測
  • 慢性病管理
    • 2018-2030年市場估計與預測
  • 臨床決策支持
    • 2018-2030年市場估計與預測
  • 詐欺檢測與預防
    • 2018-2030 年市場估計與預測
  • 其他
    • 2018-2030 年市場估計與預測

第6章臨床風險分組解決方案市場：最終用途的估計和趨勢分析

  • 全球臨床風險分組解決方案市場：按最終用途分類的儀表板
  • 全球臨床風險分組解決方案市場：最終用途的變異分析
  • 按最終用途分類的收益
  • 醫院/診所
  • 門診手術中心
  • 長期照護中心
  • 其他

第7章臨床風險分組解決方案市場：按產品、應用和最終用途進行區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2023年主要企業市場佔有率分析
    • Conduent Inc.
    • HBI Solutions
    • 3M
    • Cerner（Oracle）
    • Optum Inc.
    • Reveleer
    • Nuance Communications, Inc.
    • Lightbeam
    • Health Catalyst
Product Code: GVR-4-68040-421-6

Clinical Risk Grouping Solution Market Growth & Trends:

The global clinical risk grouping solution market size is anticipated to reach USD 1.67 billion by 2030 and is anticipated to expand at a CAGR of 13.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses various tools and technologies designed to assess and manage patient risk within healthcare settings effectively.

The progress made in data analytics and technology is crucial for propelling the market forward. Incorporating artificial intelligence (AI) and machine learning (ML) into clinical risk grouping solutions significantly improves their ability to predict outcomes, enabling healthcare providers to make better-informed decisions.

As healthcare providers strive to enhance patient outcomes while controlling expenses, the necessity for comprehensive population health management solutions has become increasingly important. These solutions empower healthcare organizations to analyze patient data effectively, pinpoint high-risk individuals, and implement preventive strategies.

Clinical Risk Grouping Solution Market Report Highlights:

  • Based on product, software held the largest market share of 77.46% in 2023. The rising use of electronic health records (EHRs) and advanced analytics tools has driven the demand for software solutions to accurately classify patients according to their clinical risks, support personalized treatment plans, and enhance patient outcomes.
  • Based on application, Population health management held the largest market share of 33.20% in 2023. This segment consolidates patient data from diverse sources, such as electronic health records, claims data, and social determinants of health, to pinpoint high-risk individuals and devise customized interventions to enhance overall health outcomes.
  • Based on end use, hospitals and clinic dominated the market with the largest revenue share of 48.30% in 2023.These institutions employ clinical risk grouping solutions to classify patients according to their health conditions, treatment requirements, and potential risks, enabling personalized care plans that can improve patient management and lower costs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Risk Grouping Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising consumer awareness regarding risk management
      • 3.2.1.2. Implementation of big data solutions
      • 3.2.1.3. Increasing focus on AI & Machine Learning
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Patient Data Privacy Concerns
  • 3.3. Clinical Risk Grouping Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Clinical Risk Grouping Solutions Market: Product Estimates & Trend Analysis

  • 4.1. Global Clinical Risk Grouping Solutions Market: Product Dashboard
  • 4.2. Global Clinical Risk Grouping Solutions Market: Product Movement Analysis
  • 4.3. Global Clinical Risk Grouping Solutions Market Estimates and Forecasts, by Product, Revenue (USD Million)
  • 4.4. Software
    • 4.4.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Private cloud
      • 4.4.2.1. Private cloud market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Public cloud
      • 4.4.3.1. Public cloud market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Hybrid cloud
      • 4.4.4.1. Hybrid cloud market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Risk Grouping Solutions Market: Application Estimates & Trend Analysis

  • 5.1. Global Clinical Risk Grouping Solutions Market: Application Dashboard
  • 5.2. Global Clinical Risk Grouping Solutions Market: Application Movement Analysis
  • 5.3. Global Clinical Risk Grouping Solutions Market by Application, Revenue
  • 5.4. Population health management
    • 5.4.1. Population health management market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Chronic disease management
    • 5.5.1. Chronic disease management market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical decision support
    • 5.6.1. Clinical decision support market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Fraud detection and prevention
    • 5.7.1. Fraud detection and prevention market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Other
    • 5.8.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Risk Grouping Solutions Market: End Use Estimates & Trend Analysis

  • 6.1. Global Clinical Risk Grouping Solutions Market: End Use Dashboard
  • 6.2. Global Clinical Risk Grouping Solutions Market: End Use Movement Analysis
  • 6.3. Global Clinical Risk Grouping Solutions Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 6.4. Hospitals & Clinics
    • 6.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Ambulatory surgical centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Long term care centers
    • 6.6.1. Long term care centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Risk Grouping Solutions Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. Conduent Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. HBI Solutions
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. 3M
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Cerner (Oracle)
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Optum Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Reveleer
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Nuance Communications, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Lightbeam
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Health Catalyst
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 26 France Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 48 China Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 49 China Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 54 India Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 67 Latin America Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 70 Brazil Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA Clinical Risk Grouping Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 77 MEA Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 78 MEA Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Clinical Risk Grouping Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Clinical Risk Grouping Solutions market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Clinical Risk Grouping Solutions market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Clinical Risk Grouping Solutions market: market outlook
  • Fig. 7 Clinical Risk Grouping Solutions competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Clinical Risk Grouping Solutions market driver impact
  • Fig. 11 Clinical Risk Grouping Solutions market restraint impact
  • Fig. 12 Clinical Risk Grouping Solutions market: Product movement analysis
  • Fig. 13 Clinical Risk Grouping Solutions market: Product outlook and key takeaways
  • Fig. 14 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Private cloud market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Public cloud market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Hybrid cloud market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Clinical Risk Grouping Solutions market: Application movement analysis
  • Fig. 20 Clinical Risk Grouping Solutions market: Application outlook and key takeaways
  • Fig. 21 Population health management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chronic disease management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Clinical decision support market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Fraud detection and prevention market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Clinical Risk Grouping Solutions market: End Use movement analysis
  • Fig. 27 Clinical Risk Grouping Solutions market: End Use outlook and key takeaways
  • Fig. 28 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Long term care centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global Clinical Risk Grouping Solutions market: Regional movement analysis
  • Fig. 33 Global Clinical Risk Grouping Solutions market: Regional outlook and key takeaways
  • Fig. 34 Global Clinical Risk Grouping Solutions market share and leading players
  • Fig. 35 North America, by country
  • Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. key country dynamics
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Canada key country dynamics
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico key country dynamics
  • Fig. 42 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 UK key country dynamics
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany key country dynamics
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France key country dynamics
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy key country dynamics
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain key country dynamics
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark key country dynamics
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden key country dynamics
  • Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway key country dynamics
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 China key country dynamics
  • Fig. 62 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Japan key country dynamics
  • Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand key country dynamics
  • Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea key country dynamics
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil key country dynamics
  • Fig. 75 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina key country dynamics
  • Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa key country dynamics
  • Fig. 80 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Saudi Arabia key country dynamics
  • Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 UAE key country dynamics
  • Fig. 84 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Kuwait key country dynamics
  • Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Market share of key market players- Clinical Risk Grouping Solutions market